Results 181 to 190 of about 36,270 (266)

Infection prevention and control: Qualitative study of the preparedness and response of Christian health Association of Ghana to Marburg virus disease in Ghana [PDF]

Herman Nuake Kofi Agboh, George Adjeisah Adjei, Grace Adjei Okai, Caroline Awotwe, Benjamin Martey Ossom, Lily Yarney   +5 more
openalex   +1 more source

Identification of potential VP40 inhibitor of Marburg virus through molecular docking, pharmacokinetic analysis and molecular dynamics simulation. [PDF]

Sci Rep
Das R, Bhattarai A, Tamang B, Thakur N.
europepmc   +1 more source

Inhibition of Lassa and Marburg Virus Production by Tetherin

, 2008
Toshie Sakuma, Takeshi Noda, Shuzo Urata, Yoshihiro Kawaoka, Jiro Yasuda   +4 more
openalex   +1 more source

Kinetics of hematological and biochemical biomarkers are key tools for monitoring disease progression in Marburg virus-infected patients in Rwanda. [PDF]

Sci Rep
Mugisha JC, Kayigi E, Gahamanyi N, Uwayo HD, Umwanankabandi F, Gashema P, Rwagasore E, Turatsinze D, Nkeshimana M, Gashegu M, Ntagwabira E, Makayoto L, Ngabonziza JCS, Mukagatare I, Tuyishime A, Rujeni N, Mutesa L, Seruyange E, Musafiri S, Twagirumugabe T, Harelimana JD, Muvunyi CM.   +21 more
europepmc   +1 more source

Process Intensification for Recombinant Marburg Virus Glycoprotein Production Using <i>Drosophila</i> S2 Cells. [PDF]

Eng Life Sci
Göbel S, Mayerlen L, Eiser IY, Fichtmueller L, Clements D, Reichl U, Genzel Y, Lehrer A.   +7 more
europepmc   +1 more source

Genomic and transmission dynamics of the 2024 Marburg virus outbreak in Rwanda. [PDF]

Nat Med
Butera Y, Mutesa L, Parker E, Muvunyi R, Umumararungu E, Ayitewala A, Musabyimana JP, Olono A, Sesonga P, Ogunsanya O, Kabalisa E, Adedokun O, Gahima N, Irankunda L, Mutezemariya C, Niyonkuru R, Uwituze A, Uwizera I, Kagame J, Umugwaneza A, Rwabuhihi J, Umwanankabandi F, Mbonitegeka V, Ntagwabira E, Kayigi E, Izuwayo G, Murenzi H, Mukankwiro T, Tuyiringire N, Uwimana JMV, Gasengayire A, Sindayiheba R, Onyeugo GU, Aragaw M, Gitundu L, Bigirimana R, Fallah M, Ejikeme A, Sembuche S, Kabanda A, Mugisha JC, Francis EES, Gashema P, Ndayisenga J, Rugamba A, Kanyabwisha F, Murenzi G, Happi A, Ngabonziza JCS, Gashegu M, Ahmed A, Bigirimana N, Rwagasore E, Semakula M, Rwabihama JP, Musanabaganwa C, Seruyange E, Nkeshimana M, Twagirumugabe T, Turatsinze D, Remera E, Gahamanyi N, Tessema SK, Mukagatare I, Nsanzimana S, Happi C, Muvunyi CM.   +66 more
europepmc   +1 more source

Identification of Promising Marburg Virus VP24 Inhibitors using Molecular Simulations [PDF]

Abassanam Seini, Seraphin Benjamin Ngachilindi Mbeket, Jean Jules Fifen, Jeanet Conradie   +3 more
openalex   +1 more source

Thirteen-Year Sequelae of Marburg Virus Disease Survival: Persistent Cardiometabolic, Immunometabolic, and Haematological Alterations in the Absence of Psychological Morbidity. [PDF]

Pathogens
Serwanga J, Kaweesa RE, Ssebwana JK, Odoch G, Wayesu RR, Ntabadde AD, Mukisa D, Ejou P, FiloStudy Team, Lutwama JJ, Kaleebu P.   +10 more
europepmc   +1 more source

Marburg virus disease outbreak in Rwanda, 2024: Current efforts and calls to action to mitigate the outbreak in Rwanda

Yves Gashugi, Louange Bienvenu Byiringiro, Janvier Rukundo, Josias Izabayo, Vincent Sezibera, Jopseph Kalisa   +5 more
openalex   +2 more sources

Ebola Virus Disease and Marburg Disease in Pregnancy

, 2015
Lisa M. Bebell, Laura E. Riley
openalex   +2 more sources